Safety profile of colocasia esculenta tuber extracts in benign prostate hyperplasia

5Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Introduction: This study was motivated by the increasing global incidence of benign prostatic hyperplasia (BPH) and the promising potential of nutraceuticals as complementary therapies in ameliorating its burden. We report the safety profile of C. esculenta tuber extracts, a novel nutraceutical in benign prostate hyperplasia in a rat model. Methods: In this study, forty-five male albino rats were randomly assigned to 9 groups of 5 rats each. Group 1 (normal control) received olive oil and normal saline. Group 2 (BPH untreated group) received 3 mg/kg of testosterone propionate (TP) and normal saline, and group 3 (positive control) received 3 mg/kg of TP and 5 mg/kg of finasteride. Treatment groups 4, 5, 6, 7, 8, and 9 received 3 mg/kg of TP and a middle dose (200 mg/kg) of LD50 of ethanol crude tuber extract of C. esculenta (ECTECE) or hexane, dichloromethane, butanone, ethyl acetate and aqueous fractions of ECTECE respectively for a period of 28 days. Results: The negative controls showed a significant (p < 0.05) increase in mean relative prostate weight (approximately 5 times) as well as a reduction in relative testes weight (approximately 1.4 times less). There was no significant (p > 0.05) difference in the mean relative weights of most vital organs: liver, kidneys, and heart. This was also observed in hematological parameters: RBC, hemoglobin, HCT, MCV, MCH, MCHC, and platelets counts. In general, we note that the effects of the well-established drug finasteride on the biochemical parameters and histology of selected organs are comparable to those of C. esculenta fractions. Conclusion: This study demonstrates that C. esculenta tuber extracts provide potentially safe nutraceutical if applied in the management of benign prostate hyperplasia based on a rat model.

References Powered by Scopus

Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study

866Citations
N/AReaders
Get full text

Tissue processing and hematoxylin and eosin staining

740Citations
N/AReaders
Get full text

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017

725Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new noninvasive approach

2Citations
N/AReaders
Get full text

Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia

1Citations
N/AReaders
Get full text

Ameliorative Potential of Pumpkin Seed Oil (Cucurbita pepo L.) Against Tramadol-Induced Oxidative Stress

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Tusubira, D., Aja, P. M., Munezero, J., Ssedyabane, F., Namale, N., Ifie, J. E., … Okoboi, J. (2023). Safety profile of colocasia esculenta tuber extracts in benign prostate hyperplasia. BMC Complementary Medicine and Therapies, 23(1). https://doi.org/10.1186/s12906-023-04018-4

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

75%

Professor / Associate Prof. 1

25%

Readers' Discipline

Tooltip

Immunology and Microbiology 2

33%

Engineering 2

33%

Medicine and Dentistry 1

17%

Pharmacology, Toxicology and Pharmaceut... 1

17%

Save time finding and organizing research with Mendeley

Sign up for free